XORTX Therapeutics Stock (NASDAQ:XRTX), Quotes and News Summary

Q: What sector and industry does XORTX Therapeutics (XRTX) operate in?

XORTX Therapeutics is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.

XORTX Therapeutics Stock (NASDAQ: XRTX) stock price, news, charts, stock research, profile.

Open	$2.955
Close	$2.997
Volume / Avg.	13.010K / 48.777K
Day Range	2.900 - 3.000
52 Wk Range	1.980 - 648.810
Market Cap	$8.638M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	39
Short Interest	0.74%
Days to Cover	1

Recent News

Why Science Applications International Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session

Shares of Science Applications International Corporation (NYSE: SAIC) fell sharply during Monday’s session after the company reported financial fourth-quarter EPS below estimates.

Avi Kapoor

Why United Natural Foods Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

Shares of United Natural Foods, Inc. (NYSE: UNFI) fell sharply during Wednesday’s session following second-quarter results.

Avi Kapoor

Why SOPHiA GENETICS Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

Shares of SOPHiA GENETICS SA (NASDAQ: SOPH) fell sharply during Tuesday’s session after the company reported worse than expected fourth-quarter earnings and issued 2024 guidance.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trend

Jan

Buy

Hold

Sell

Strong Sell

Analyst Rating

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

About

Sector

Healthcare

Industry

N/A

XORTX Therapeutics Inc is a clinical-stage biotechnology company focused on identifying, developing,...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy XORTX Therapeutics (XRTX) stock?

You can purchase shares of XORTX Therapeutics (NASDAQ: XRTX) through any online brokerage.

View our list of the best stock brokerages.

Who are XORTX Therapeutics's (XRTX) competitors?

There are no as such competitors for XORTX Therapeutics.

What is the target price for XORTX Therapeutics (XRTX) stock?

The latest price target for XORTX Therapeutics (NASDAQ: XRTX) was reported by Alliance Global Partners on Thursday, January 4, 2024. The analyst firm set a price target for 14.00 expecting XRTX to rise to within 12 months (a possible 369.80% upside). 1 analyst firms have reported ratings in the last year.

Current Stock Price for XORTX Therapeutics (XRTX)?

The stock price for XORTX Therapeutics (NASDAQ: XRTX) is $2.98 last updated Today at April 19, 2024 at 5:40 PM EDT.

Does XORTX Therapeutics (XRTX) pay a dividend?

A quarterly cash dividend of $0.07 per share of Class A Common Stock. The quarterly cash dividend was payable on February 17, 2014 to stockholders of record on January 31, 2014.

When is XORTX Therapeutics (NASDAQ:XRTX) reporting earnings?

XORTX Therapeutics’s Q1 earnings are confirmed for Tuesday, May 14, 2024.

Is XORTX Therapeutics (XRTX) going to split?

There is no upcoming split for XORTX Therapeutics.

What sector and industry does XORTX Therapeutics (XRTX) operate in?

XORTX Therapeutics is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.